Identifying chemogenetic interactions from CRISPR knockout screens with drugZ

Chemogenetic profiling enables the identification of gene mutations that enhance or suppress the activity of small molecules. This knowledge provides insights into drug mechanism-of-action, genetic vulnerabilities, and resistance mechanisms, all of which may help stratify patient populations. We present drugZ, an algorithm for identifying both synergistic and suppressor chemogenetic interactions from highly sensitive CRISPR screens, available at github.com/hart-lab/drugz. In screens for interactions with a poly(ADP-ribose) polymerase (PARP) inhibitor, DrugZ identifies a greater fraction of the homologous recombination repair pathway than contemporary methods, and confirms KEAP1 loss as a resistance factor for ERK inhibitors.